North America Veterinary Ocular Medicine Market Size, by Antivirals Product Classification (2024-2032)

The North America Veterinary Ocular Medicine Market demonstrated significant evolution in 2024, with branded veterinary products valued at USD 6,096.81 Thousand, establishing the segment’s dominance. In 2025, the North America Veterinary Ocular Medicine market is estimated to reach USD 6,419.23 Thousand for branded products and USD 5,472.35 Thousand for generic products, reflecting steady adoption and increasing clinical integration across veterinary practices. Compounded drugs and off-label human ocular treatments are also gaining traction, projected at USD 2,044.16 Thousand and USD 1,427.05 Thousand, respectively.

From 2026 to 2032, the North America Veterinary Ocular Medicine Market is projected to expand consistently, driven by advancements in formulation science and rising demand for specialized veterinary ophthalmic care. Branded veterinary products are anticipated to reach USD 10,268.43 Thousand by 2032, while generic veterinary products are expected to total USD 9,889.86 Thousand. Meanwhile, compounded drugs are forecast to increase to USD 3,606.78 Thousand, and off-label human ocular treatments to USD 2,139.59 Thousand, underscoring the market’s sustained innovation and broadening therapeutic adoption across North America.